These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 29850629)

  • 1. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
    Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
    Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
    Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
    Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
    Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations and potential strategies of immune checkpoint blockade in age-related neurodegenerative disorders.
    Lasheen NN; Allam S; Elgarawany A; Aswa DW; Mansour R; Farouk Z
    J Physiol Sci; 2024 Sep; 74(1):46. PubMed ID: 39313800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Parkinson's disease.
    Wersinger C; Sidhu A
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):221-42. PubMed ID: 14561187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.
    Rokad D; Ghaisas S; Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Brain Res Bull; 2017 Jul; 133():60-70. PubMed ID: 27993598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
    Chistiakov DA; Chistiakov AA
    Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease.
    Hirsch EC; Standaert DG
    Mov Disord; 2021 Jan; 36(1):16-24. PubMed ID: 32357266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of innate immunity and inflammation in Parkinson´s disease.
    Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
    Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.
    Lastres-Becker I; Ulusoy A; Innamorato NG; Sahin G; Rábano A; Kirik D; Cuadrado A
    Hum Mol Genet; 2012 Jul; 21(14):3173-92. PubMed ID: 22513881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.
    Hatton SL; Pandey MK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on immunity and inflammation in Parkinson disease pathology.
    Joshi N; Singh S
    J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A; Winner B; Prots I
    Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune system in Parkinson's disease: what we know so far.
    Roodveldt C; Bernardino L; Oztop-Cakmak O; Dragic M; Fladmark KE; Ertan S; Aktas B; Pita C; Ciglar L; Garraux G; Williams-Gray C; Pacheco R; Romero-Ramos M
    Brain; 2024 Oct; 147(10):3306-3324. PubMed ID: 38833182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.